Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Chicago
United States
Zip Code
Hellums, Elizabeth K; Markert, James M; Parker, Jacqueline N et al. (2005) Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model. Neuro Oncol 7:213-24
Whitley, Richard J (2003) Smallpox: a potential agent of bioterrorism. Antiviral Res 57:7-12
Whitley, Richard J; Roizman, Bernard (2002) Herpes simplex viruses: is a vaccine tenable? J Clin Invest 110:145-51
Whitley, Richard J; Gnann, John W (2002) Viral encephalitis: familiar infections and emerging pathogens. Lancet 359:507-13
Markert, J M; Parker, J N; Gillespie, G Y et al. (2001) Genetically engineered human herpes simplex virus in the treatment of brain tumours. Herpes 8:17-22
Parker, J N; Gillespie, G Y; Love, C E et al. (2000) Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A 97:2208-13
Markert, J M; Gillespie, G Y; Weichselbaum, R R et al. (2000) Genetically engineered HSV in the treatment of glioma: a review. Rev Med Virol 10:17-30
Tran, L C; Kissner, J M; Westerman, L E et al. (2000) A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo. Proc Natl Acad Sci U S A 97:1818-22
Burns, S M; Hull, S I (1998) Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. Infect Immun 66:4244-53
Whitley, R J; Kimberlin, D W; Roizman, B (1998) Herpes simplex viruses. Clin Infect Dis 26:541-53;quiz 554-5

Showing the most recent 10 out of 42 publications